{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T15:30:26Z","timestamp":1790177426045,"version":"4.1.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12969-016-0076-6","type":"journal-article","created":{"date-parts":[[2016,3,12]],"date-time":"2016-03-12T01:22:24Z","timestamp":1457745744000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Biologic agents in juvenile spondyloarthropathies"],"prefix":"10.1186","volume":"14","author":[{"given":"Mar\u00eda Martha","family":"Katsicas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,12]]},"reference":[{"issue":"3","key":"76_CR1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0889-857X(02)00033-9","volume":"28","author":"VR Burgos","year":"2002","unstructured":"Burgos VR. The Juvenile onset Spondyloarthritides. Rheum Clin North Am. 2002;28(3):531\u201360.","journal-title":"Rheum Clin North Am"},{"issue":"10","key":"76_CR2","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/art.1780341003","volume":"34","author":"M Dougados","year":"1991","unstructured":"Dougados M, van der Linden S, Juhlin R, Huitfelt B, Amor B, Calin A, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification of spondylarthropathy. Arthritis Rheum. 1991;34(10):1218\u201327.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"76_CR3","first-page":"1991","volume":"25","author":"RE Petty","year":"1998","unstructured":"Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol. 1998;25(10):1991\u20134.","journal-title":"J Rheumatol"},{"issue":"8","key":"76_CR4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nrrheum.2010.103","volume":"6","author":"RA Colbert","year":"2010","unstructured":"Colbert RA. Classification of Juvenile Spondyloarthritis: Enthesitis-related arthritis and beyond. Nat Rev Rheumatol. 2010;6(8):477\u201385.","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"76_CR5","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/art.1780210603","volume":"21","author":"V Wright","year":"1978","unstructured":"Wright V. Seronegative polyarthritis: a unified concept. Arthritis Rheum. 1978;21(6):619\u201333.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"76_CR6","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1002\/art.1780250902","volume":"25","author":"A Rosenberg","year":"1982","unstructured":"Rosenberg A, Petty R. A syndrome of seronegative enthesopathy and arthropathy in children. Arthritis Rheum. 1982;25(9):1041\u20137.","journal-title":"Arthritis Rheum"},{"issue":"12","key":"76_CR7","first-page":"2737","volume":"28","author":"L Berntson","year":"2001","unstructured":"Berntson L, Fasth A, Andersson-G\u00e4re B, Kristinsson J, Lahdenne P, Marhaug G, et al. Construct validity of ILAR and EULAR criteria in juvenile idiopathic arthritis: a population based incidence study from the Nordic countries. International League of Associations for Rheumatology. European League Against Rheumatism. J Rheumatol. 2001;28(12):2737\u201343.","journal-title":"J Rheumatol"},{"issue":"1","key":"76_CR8","first-page":"111","volume":"29","author":"E Demirkaya","year":"2001","unstructured":"Demirkaya E, Ozen S, Bilginer Y, Ayaz NA, Makay BB, Unsal E, et al. The distribution of juvenile idiopathic arthritis in the Eastern Mediterranean: results from the registry of the Turkish Paediatric Rheumatology Association. Clin Exp Rheumatol. 2001;29(1):111\u20136.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"76_CR9","first-page":"827","volume":"17","author":"AM Rosenberg","year":"1990","unstructured":"Rosenberg AM. Analysis of a pediatric rheumatology clinic population. J Rheumatol. 1990;17(6):827\u201330.","journal-title":"J Rheumatol"},{"issue":"55","key":"76_CR10","first-page":"S131","volume":"27","author":"G Horneff","year":"2009","unstructured":"Horneff G, Burgos VR. Juvenile Idiopathic Arthritis. Subgroup charcateristics and comparisons between rheumatic arthritis-like subgroups and ankylosing spondylitis-like subgroups. Clin Exp Rheumatol. 2009;27(55):S131\u20138.","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"76_CR11","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3899\/jrheum.100889","volume":"37","author":"JD Taurog","year":"2010","unstructured":"Taurog JD. The role of HLA- B27 in spondyloarthritis. J Rheumatol. 2010;37(12):2606\u201316.","journal-title":"J Rheumatol"},{"issue":"11","key":"76_CR12","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.3899\/jrheum.100090","volume":"37","author":"I Pagnini","year":"2010","unstructured":"Pagnini I, Savelli S, Matucci-Cerinic M, Fonda C, Cimaz R, Simonini G. Early predictors of juvenile sacroiliitis in enthesitis \u2013related arthritis. J Rheumatol. 2010;37(11):2395\u2013401.","journal-title":"J Rheumatol"},{"issue":"11","key":"76_CR13","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1002\/art.22181","volume":"54","author":"B Flato","year":"2006","unstructured":"Flato B, Hoffmann\u2013Vold AM, Reiff A, Forre O, Lien G, Vinje O. Long- Term outcome and prognostic factors in enthesitis-related arthritis: a case-control study. Arthritis Rheum. 2006;54(11):3573\u201382.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"76_CR14","first-page":"1883","volume":"21","author":"B Amor","year":"1994","unstructured":"Amor B, Santos RS, Nahal R, Listrat V, Dougados M. Predictive factors for the longterm outcome of spondyloarthropathies. J Rheumatol. 1994;21(10):1883\u20137.","journal-title":"J Rheumatol"},{"issue":"1","key":"76_CR15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1546-0096-10-10","volume":"10","author":"R Burgos-Vargas","year":"2012","unstructured":"Burgos-Vargas R. The assessment of the spondyloarthritis international society concept and criteria for the classification of axial spondyloarthritis and peripheral spondyloarthritis: A critical appraisal for the pediatric rheumatologist. Pediatr Rheumatol Online J. 2012;10(1):10\u20134.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"6","key":"76_CR16","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/art.23704","volume":"59","author":"MM Ward","year":"2008","unstructured":"Ward MM, Reveille JD, Learch TJ, Davis Jr JC, Weisman MH. Occupational physical activities and longterm functional and radiographic outcomes in patients with ankylosing spondylitis. Arthritis Rheum. 2008;59(6):822\u201332.","journal-title":"Arthritis Rheum"},{"key":"76_CR17","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev.immunol.25.022106.141627","volume":"27","author":"SL Masters","year":"2009","unstructured":"Masters SL, Simon A, Aksentijevich I, Kastner DL. Horror Autoinflammaticus: the molecular pathophysiology of autoinflammatory disease. Annu Rev Immunol. 2009;27:621\u201368.","journal-title":"Annu Rev Immunol"},{"issue":"8","key":"76_CR18","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1371\/journal.pmed.0030297","volume":"3","author":"D McGonagle","year":"2006","unstructured":"McGonagle D, McDermott M. A proposed classification of inmmunological diseases. PLoS Med. 2006;3(8):1242\u20138.","journal-title":"PLoS Med"},{"key":"76_CR19","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nrrheum.2012.41","volume":"8","author":"J Reveille","year":"2012","unstructured":"Reveille J. Genetics of Spondyloarthritis- Beyond the MHC. Nat Rev Rheumatol. 2012;8:296\u2013304.","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"76_CR20","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1136\/ard.58.10.598","volume":"58","author":"JH Ringrose","year":"1999","unstructured":"Ringrose JH. HLA-B27 associated spondyloarthropathy, an autoimmune disease based on crossreactivity between bacteria and HLA-B27?. Ann Rheum Dis. 1999;58(10):598\u2013610.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"76_CR21","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/art.38963","volume":"67","author":"RB Shittenhelm","year":"2015","unstructured":"Shittenhelm RB, Sian TC, Wilmann PG, Dudek NL, Purcell AW. Revisiting the arthritogenicpeptide theory: quantitative not qualitative changes in the peptide repertoire of HLA-B27 allotypes. Arthritis Rheumatol. 2015;67(3):702\u201313.","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"76_CR22","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/art.1780391013","volume":"39","author":"AA Grom","year":"1996","unstructured":"Grom AA, Murray KJ, Luyrink L, Emery H, Passo MH, Glass DN, et al. Patterns of expression of tumor necrosis factor B and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondyloarthropathy. Arthritis Rheum. 1996;39(10):1703\u201310.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"76_CR23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/art.1780380407","volume":"38","author":"J Braun","year":"1995","unstructured":"Braun J, Bollow M, Neure L, Seilpet E, Seyrekbasan F, Herbst H, et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum. 1995;38(4):499\u2013505.","journal-title":"Arthritis Rheum"},{"key":"76_CR24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/rheumatology\/ket375","volume":"53","author":"M Schulz","year":"2014","unstructured":"Schulz M, Dotzlaw H, Neeck G. Ankylosing Spondylitis and rheumatoid arthritis: serum levels of TNF\u03b1 and its soluble receptors during the course of therapy wirh etanercept and infliximab. Rheumatology. 2014;53:270\u20134.","journal-title":"Rheumatology"},{"issue":"7","key":"76_CR25","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"JP Sherlock","year":"2012","unstructured":"Sherlock JP, Joyce-Shaik B, Turner SP, Chao CC, Sathe M, Grein J, et al. IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t\u2009+\u2009CD3\u2009+\u2009CD4-CD8-entheseal resident T cells. Nat Medicine. 2012;18(7):1069\u201376.","journal-title":"Nat Medicine"},{"issue":"1","key":"76_CR26","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.0105-2896.2009.00865.x","volume":"233","author":"RA Colbert","year":"2010","unstructured":"Colbert RA, DeLay ML, Klenk EI, Layh-Schmitt G. From HLA-B27 to spondyloarthritis: a journey through the ER. Immunol Rev. 2010;233(1):181\u2013202.","journal-title":"Immunol Rev"},{"issue":"11","key":"76_CR27","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00296-009-0883-x","volume":"29","author":"X Wang","year":"2009","unstructured":"Wang X, Lin Z, Wei Q, Jiang Y, Gu J. Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis. Rheumatol Int. 2009;29(11):1343\u20137.","journal-title":"Rheumatol Int"},{"issue":"1","key":"76_CR28","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/art.22295","volume":"56","author":"MJ Turner","year":"2007","unstructured":"Turner MJ, Delay ML, Bai S, Klenk E, Colbert RA. HLA-B27 up-regulation causes accumulation of misfolded heavy chains and correlates with the magnitude of the unfolded protein response in transgenic rats: Implications for the pathogenesis of spondylarthritis-like disease. Arthritis Rheum. 2007;56(1):215\u201323.","journal-title":"Arthritis Rheum"},{"issue":"5","key":"76_CR29","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1093\/rheumatology\/40.5.522","volume":"40","author":"MC Honorati","year":"2001","unstructured":"Honorati MC, Meliconi R, Pulsatelli L, Can\u00e9 S, Frizziero L, Facchini A. High in vivo expression of interleukin-17 receptor in synovial endothelial cells and chondrocytes from arthritis patients. Rheumatology (Oxford). 2001;40(5):522\u20137.","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"76_CR30","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1002\/art.23655","volume":"58","author":"C Jandus","year":"2008","unstructured":"Jandus C, Bioley G, Rivals J, Dudler J, Speiser D, Romero P. Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondyloarthritides. Arthritis & Rheum. 2008;58(8):2307\u201317.","journal-title":"Arthritis & Rheum"},{"issue":"3","key":"76_CR31","first-page":"515","volume":"35","author":"S Agarwal","year":"2008","unstructured":"Agarwal S, Misra R, Aggarwal A. Interleukin 17 levels are increased in Juvenile Idiopathic Arthritis synovial fluid and induce synovial fibroblasts to produce proinflammatory cytokines and matrix metalloproteinases. J Rheumatol. 2008;35(3):515\u20139.","journal-title":"J Rheumatol"},{"issue":"1","key":"76_CR32","first-page":"120","volume":"27","author":"GM Alenius","year":"2009","unstructured":"Alenius GM, Eriksson C, Rantap\u00e4\u00e4 Dahlqvist S. Interleukin-6 and soluble interleukin-2 receptor alpha-markers of inflammation in patients with psoriatic arthritis? Clin Exp Rheumatol. 2009;27(1):120\u20133.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"76_CR33","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/ard.2005.037465","volume":"65","author":"RJ Fran\u00e7ois","year":"2006","unstructured":"Fran\u00e7ois RJ, Neure L, Sieper J, Braun J. Immunohistological examination of open sacroiliac biopsies of patients with ankylosing spondylitis: detection of tumour necrosis factor alpha in two patients with early disease and transforming growth factor beta in three more advanced cases. Ann Rheum Dis. 2006;65(6):713\u201320.","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"76_CR34","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1002\/art.23044","volume":"56","author":"RG Lambert","year":"2007","unstructured":"Lambert RG, Salonen D, Rahman P, Inman RD, Wong RL, Einstein SG, et al. Adalimumab significantly reduces both spinal and sacroiliac joint inflammation in patients with ankylosing spondylitis: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum. 2007;56(12):4005\u201314.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"76_CR35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/art.24132","volume":"60","author":"WP Maksymowych","year":"2009","unstructured":"Maksymowych WP, Chiowchanwisawakit P, Clare T, Pedersen SJ, Ostergaard M, Lambert RG. Inflammatory lesions of the spine on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis: evidence of a relationship between inflammation and new bone formation. Arthritis Rheum. 2009;60(1):93\u2013102.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"76_CR36","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1002\/art.38068","volume":"65","author":"P Machado","year":"2013","unstructured":"Machado P. Anti-tumor necrosis factor and new bone formation in Ankylosing Spondylitis: the controversy continues. Arthritis Rheum. 2013;65(10):2537\u201340.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"76_CR37","first-page":"2055","volume":"31","author":"M Henrickson","year":"2004","unstructured":"Henrickson M, Reiff A. Prolonged efficacy of etanercept in refractory enthesitis-related arthritis. J Rheumatol. 2004;31(10):2055\u201361.","journal-title":"J Rheumatol"},{"issue":"7","key":"76_CR38","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1002\/art.21121","volume":"52","author":"SM Tse","year":"2005","unstructured":"Tse SM, Burgos-Vargas R, Laxer RM. Anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondylarthropathy. Arthritis Rheum. 2005;52(7):2103\u20138.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"76_CR39","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jbspin.2008.03.008","volume":"76","author":"M Sulpice","year":"2009","unstructured":"Sulpice M, Deslandre CH, Quartier P. Efficacy and safety of TNF\u03b1 antagonist therapy in patients with juvenile spondyloarthropathies. Joint Bone Spine. 2009;76(1):24\u20137.","journal-title":"Joint Bone Spine"},{"issue":"10","key":"76_CR40","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.3899\/jrheum.110145","volume":"38","author":"M Otten","year":"2011","unstructured":"Otten M, Prince F, Twilt M, Ten Cate R, Armbrust W, Hoppenreijs EP, et al. Tumor Necrosis Factor-blocking Agents for Children with enthesitis- related arthritis- data from the Dutch arthritis and biologicals in children register, 1999\u20132010. J Rheumatol. 2011;38(10):2258\u2013063.","journal-title":"J Rheumatol"},{"issue":"5","key":"76_CR41","doi-asserted-by":"crossref","first-page":"R230","DOI":"10.1186\/ar4072","volume":"14","author":"G Horneff","year":"2012","unstructured":"Horneff G, Fitter S, Foeldvari I, Minden K, Kuemmerle-Deschner J, Tzaribacev N, et al. Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement. Arthritis Res Ther. 2012;14(5):R230.","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"76_CR42","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/annrheumdis-2012-203046","volume":"73","author":"G Horneff","year":"2014","unstructured":"Horneff G, Burgos Vargas R, Constantin T, Foeldvari I, Vojinovic J, Chasnyc VG, et al. Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study. Ann Rheum Dis. 2014;73(6):1114\u201322.","journal-title":"Ann Rheum Dis"},{"key":"76_CR43","doi-asserted-by":"crossref","first-page":"S793","DOI":"10.1002\/acr.21879","volume":"65","author":"R Burgos Vargas","year":"2013","unstructured":"Burgos Vargas R, Shirley M, Tse S, Unnebrink K, Anderson J. Efficacy and safety of adalimumab in pediatric patients with Enthesitis Related Arthritis. Arthritis Rheum. 2013;65:S793.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"76_CR44","first-page":"424","volume":"32","author":"B Hugle","year":"2014","unstructured":"Hugle B, Burgos-Vargas R, Inman RD, O\u00b4Shea F, Laxer RM, et al. Long \u2013term outcome of anti-tumor necrosis factor alpha blockade in the treatment of juvenile spondyloarthritis. Clin Exp Rheumatol. 2014;32(3):424\u201331.","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"76_CR45","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/art.39145","volume":"67","author":"G Horneff","year":"2015","unstructured":"Horneff G, Foeldvari I, Minden K, Trauzeddel R, Kuemmerle-Deschner J, Tenbrock K, et al. Efficacy and safety of etanercept in patients with the enthesitis- related arthritis category of Juvenile Idiopathic Arthritis. Arthritis Rheum. 2015;67(8):2240\u20139.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"76_CR46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.autrev.2008.07.011","volume":"8","author":"A Lalvani","year":"2008","unstructured":"Lalvani A, Milligton K. Screening for tuberculosis infection prior to initiation of anti-TNF therapy. Autoimmun Rev. 2008;8(2):147\u201352.","journal-title":"Autoimmun Rev"},{"issue":"6","key":"76_CR47","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1136\/ard.2010.145946","volume":"76","author":"IH Song","year":"2011","unstructured":"Song IH, Heldman F, Rudwaleit M, Haibel H, Weiss A, Braun J, et al. Treatment of active ankylosing spondylitis with abatacept: an open \u2013label, 24 week pilot study. Ann Rheum Dis. 2011;76(6):1108\u201310.","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"76_CR48","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F","volume":"44","author":"J Anderson","year":"1986","unstructured":"Anderson J, Baron G, van der Heijde D, Felson DT, Dougados M. Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum. 1986;44(8):1876\u201386.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"76_CR49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1136\/annrheumdis-2013-203559","volume":"73","author":"J Sieper","year":"2014","unstructured":"Sieper J, Porter-Brown B, Thompson L, Harari O, Dougados M. Assessment of short-term symptomatic efficacy of tocilizumab in ankylosing spondylitis: results of randomized placebo-controlled trials. Ann Rheum Dis. 2014;73(1):95\u2013100.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"76_CR50","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.3899\/jrheum.110265","volume":"38","author":"JD Cohen","year":"2011","unstructured":"Cohen JD, Ferreira R, Jorgensen C. Ankylosing spondylitis refractory to tumor necrosis factor blockade responds to\u00a0tocilizumab. J Rheumatol. 2011;38(7):1527.","journal-title":"J Rheumatol"},{"issue":"5","key":"76_CR51","first-page":"805","volume":"30","author":"L Gossec","year":"2012","unstructured":"Gossec L, Del Castillo-Pi\u00f1ol N, Roux C, Dougados M. Lack of efficacy of\u00a0tocilizumab\u00a0in severe axial refractory\u00a0spondyloarthritis: a report of 5 patients. Clin Exp Rheumatol. 2012;30(5):805.","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"76_CR52","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/art.27383","volume":"62","author":"IH Song","year":"2010","unstructured":"Song IH, Heldman F, Rudwaleit M, Listing J, Appel H, Braun J, et al. Different response to rituximab in tumor necrosis factor blocker \u2013na\u00efve patients with active Ankylosing Spondylitis and in patients in whom tumor necrosis factor blockers have failed. Arthritis Rheum. 2010;62(5):1290\u20137.","journal-title":"Arthritis Rheum"},{"issue":"26","key":"76_CR53","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1505066","volume":"373","author":"D Baeten","year":"2015","unstructured":"Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Enery P, et al. Secukinumab, an interleukin-17A inhibitor in Ankylosing Sponylitis. NEJM. 2015;373(26):2534\u201348.","journal-title":"NEJM"},{"issue":"3","key":"76_CR54","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1136\/ard.2005.040758","volume":"65","author":"J Braun","year":"2006","unstructured":"Braun J, Davis J, Dougados M, Sieper J, van der Liden S, van der Heijde D, et al. First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis. Ann Rheum Dis. 2006;65(3):316\u201320.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"76_CR55","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1136\/ard.2006.054098","volume":"66","author":"H Haibel","year":"2007","unstructured":"Haibel H, Brandt HC, Song IH, Brandt A, Listing J, Rudwaleit M, et al. No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trial. Ann Rheum Dis. 2007;66(3):419\u201321.","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"76_CR56","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/rheumatology\/41.11.1330","volume":"41","author":"B Roychowdhury","year":"2002","unstructured":"Roychowdhury B, Bintley-Bagot S, Bulgen DY, Thompson RN, Tunn EJ, Moots RJ. Is Methotrexate effective in ankylosing spondylitis? Rheumatology. 2002;41(11):1330\u20132.","journal-title":"Rheumatology"},{"issue":"11","key":"76_CR57","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/1529-0131(199911)42:11<2325::AID-ANR10>3.0.CO;2-C","volume":"42","author":"D Clegg","year":"1999","unstructured":"Clegg D, Reda D, Abdellatif M. Comparison of sulfazalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondyloarthropathies. Arthritis Rheum. 1999;42(11):2325\u20139.","journal-title":"Arthritis Rheum"},{"key":"76_CR58","first-page":"1","volume":"2015","author":"M Ward","year":"2015","unstructured":"Ward M, Deodhar A, Akl E, Lui A, Ermann J, Gensler L, et al. American College of Rheumatology \/Spondylitis Association of America \/Spondyloarthritis researchand treatment network 2015. Recomendations for the treatment of Ankylosing Spondylitis and non radiographic axial spondyloarthris. Arthritis & Rheum. 2015;2015:1\u201317.","journal-title":"Recomendations for the treatment of Ankylosing Spondylitis and non radiographic axial spondyloarthris. Arthritis & Rheum"},{"issue":"3","key":"76_CR59","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1186\/ar3054","volume":"12","author":"M Rudwaleit","year":"2010","unstructured":"Rudwaleit M, Van den Bosch F, Kron M, Kary S, Kupper H. Effectiveness, safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy. Arthritis Res Ther. 2010;12(3):R117.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"76_CR60","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.20460","volume":"63","author":"T Beukelman","year":"2011","unstructured":"Beukelman T, Patkar NM, Saag KG, Tolleson-Rinehart S, Cron RQ, DeWitt EM, et al. American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features. Arthritis Care Res (Hoboken). 2011;63(4):465\u201382.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"12","key":"76_CR61","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1002\/acr.22411","volume":"66","author":"P Weiss","year":"2014","unstructured":"Weiss P, Colbert R, Xiao R, Feudtner C, Beukelman T, DeWitt E, et al. Development and retrospective validation of the juvenile spondyloarthitis disease activity index. Arthritis Care Res (Hoboken). 2014;66(12):1775\u201382.","journal-title":"Arthritis Care Res (Hoboken)"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-016-0076-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T23:44:28Z","timestamp":1718408668000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.ped-rheum.com\/content\/14\/1\/17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,12]]},"references-count":61,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["76"],"URL":"https:\/\/doi.org\/10.1186\/s12969-016-0076-6","relation":{},"ISSN":["1546-0096"],"issn-type":[{"value":"1546-0096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,12]]},"article-number":"17"}}